Literature DB >> 8495300

Diagnostic value of cytology for biliary stricture.

T Kurzawinski1, A Deery, B R Davidson.   

Abstract

Over the past 20 years, bile aspiration at endoscopic retrograde cholangiopancreatography or percutaneous transhepatic cholangiography has been developed for cytological diagnosis of biliary tract stricture. This safe and specific test has allowed a diagnosis to be reached before or without operation in about one-third of malignancies of the pancreas or biliary tree. The recent development of biliary brush cytology has produced better results. An endobiliary biopsy forceps is now available that may allow safe sampling of lesions causing extrinsic compression of the biliary tract. An endobiliary aspiration cytology needle has been produced that may permit non-ulcerating lesions to be diagnosed. A safe alternative to endobiliary methods is percutaneous fine-needle aspiration cytology; this yields a diagnosis in about half of patients presenting with obstructive jaundice and an imaged mass lesion.

Entities:  

Mesh:

Year:  1993        PMID: 8495300     DOI: 10.1002/bjs.1800800404

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  11 in total

1.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

2.  A prospective evaluation of cytology from biliary strictures.

Authors:  J C Mansfield; S M Griffin; V Wadehra; K Matthewson
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

3.  Biliary brush cytology: factors associated with positive yields on biliary brush cytology.

Authors:  Nasim Mahmoudi; Robert Enns; Jack Amar; Jaber AlAli; Eric Lam; Jennifer Telford
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

4.  Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts.

Authors: 
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

5.  Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases.

Authors:  C J Stewart; P R Mills; R Carter; J O'Donohue; G Fullarton; C W Imrie; W R Murray
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

6.  Early diagnosis of pancreatobiliary duct malignancies by brush cytology and biopsy.

Authors:  Gábor Elek; Tibor Gyökeres; Eszter Schäfer; Mária Burai; Ferenc Pintér; Akos Pap
Journal:  Pathol Oncol Res       Date:  2005-09-29       Impact factor: 3.201

7.  Detection of point mutations in K-ras gene at codon 12 in bile from percutaneous transhepatic choledochal drainage tubes for diagnosis of biliary strictures.

Authors:  T Ajiki; H Onoyama; M Yamamoto; T Fujimori; S Maeda; Y Saitoh
Journal:  Int J Pancreatol       Date:  1995-12

8.  Improvement of intraoperative frozen section diagnosis in patients with biliary strictures by Levovist injection into the bile duct on color Doppler ultrasonography.

Authors:  Takayuki Aimoto; Eiji Uchida; Yutaka Kawahigashi; Yoshiharu Nakamura; Akira Matsushita; Akira Katsuno; Kazumitsu Chou; Masao Kawamoto; Yoichiro Yamanaka; Takashi Tajiri; Zenya Naito
Journal:  World J Surg       Date:  2008-01       Impact factor: 3.352

9.  The diagnostic value of brush cytology alone and in combination with tumor markers in pancreaticobiliary strictures.

Authors:  Ufuk Barış Kuzu; Bülent Ödemiş; Nesrin Turhan; Erkan Parlak; Selçuk Dişibeyaz; Nuretdin Suna; Erkin Öztaş; Muhammet Yener Akpınar; Adem Aksoy; Serkan Torun; Hakan Yıldız; Ertuğrul Kayaçetin
Journal:  Gastroenterol Res Pract       Date:  2015-03-26       Impact factor: 2.260

10.  Techniques for cytologic sampling of pancreatic and bile duct lesions: The Papanicolaou Society of Cytopathology Guidelines.

Authors:  William R Brugge; John De Witt; Jason B Klapman; Raheela Ashfaq; Vinod Shidham; David Chhieng; Richard Kwon; Zubair Baloch; Matthew Zarka; Gregg Staerkel
Journal:  Cytojournal       Date:  2014-06-02       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.